🇺🇸 FDA
Patent

US 12023391

Alpha(v)beta(6) integrin-binding peptides and methods of use thereof

granted A61KA61K38/08A61K38/10

Quick answer

US patent 12023391 (Alpha(v)beta(6) integrin-binding peptides and methods of use thereof) held by The Regents of the University of California expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/08, A61K38/10, A61K38/1777, A61K47/60